NxStage Medical, Inc.·4

Mar 12, 4:28 PM ET

TOWSE MATTHEW W 4

4 · NxStage Medical, Inc. · Filed Mar 12, 2018

Insider Transaction Report

Form 4
Period: 2018-03-09
TOWSE MATTHEW W
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2018-03-095,82111,643 total
    Exercise: $0.00From: 2018-03-09Exp: 2020-03-09Common Stock (5,821 underlying)
  • Exercise/Conversion

    Common Stock

    2018-03-09+5,82130,242 total
  • Award

    Restricted Stock Unit

    2018-03-09+17,46417,464 total
    Exercise: $0.00From: 2018-03-09Exp: 2020-03-09Common Stock (17,464 underlying)
  • Tax Payment

    Common Stock

    2018-03-09$24.37/sh1,846$44,98728,396 total
Footnotes (1)
  • [F1]Award granted pursuant to the 2017 Performance Share Plan, vesting in 3 equal annual installments beginning March 9, 2018.

Documents

1 file
  • 4
    form.xmlPrimary

    PRIMARY DOCUMENT